跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
T regulatory cells
首页
药物
T regulatory cells
T regulatory cells
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
EP 3569690 B1
申请人: UNIV TOKYO
优先权: 2011
CN
EP
US
WO
31 件公开
METHODS AND COMPOSITIONS FOR ENHANCING CD4+ REGULATORY T CELLS
EP 2991646 B1
申请人: SELECTA BIOSCIENCES INC
优先权: 2013
CN
EP
US
WO
15 件公开
METHODS FOR EXPANSION OR DEPLETION OF T-REGULATORY CELLS
EP 2953634 B1
申请人: MASSACHUSETTS GEN HOSPITAL
优先权: 2013
EP
US
WO
11 件公开
SYNTHETIC NANOCARRIERS FOR GENERATING CD8+REGULATORY T CELLS FOR USE IN INDUCING TOLEROGENESIS
EP 2704715 B1
申请人: SELECTA BIOSCIENCES INC
优先权: 2011
CN
EP
US
WO
9 件公开
MARKERS SELECTIVELY DEREGULATED IN TUMOR-INFILTRATING REGULATORY T CELLS
US 2019391152 A1
申请人: CHECKMAB S R L
优先权: 2016
CN
EP
US
WO
8 件公开
METHODS FOR MODULATING REGULATORY T CELLS AND INHIBITING TUMOR GROWTH
EP 4782005 A2
申请人: UNIV LAUSANNE
优先权: 2018
CN
EP
US
WO
7 件公开
ENGINEERED REGULATORY T CELLS
EP 3997212 B1
申请人: THE CHILDRENS MERCY HOSPITAL
优先权: 2019
EP
US
WO
7 件公开
CN 114585730 A
申请人: LONDON KING COLLEGE
优先权: 2019
CN
CN 114641487 A
申请人: UCL COMMERCIAL LTD COMPANY
优先权: 2019
CN
ALS TREATMENT USING INDUCED REGULATORY T (iT REG) CELLS
EP 3880306 A4
申请人: RAPA THERAPEUTICS LLC
优先权: 2018
CN
EP
US
WO
6 件公开
CD4+CD25 T cells and Tr1-like regulatory T cells
US 8222033 B2
申请人: SCHULER GEROLD
优先权: 2003
US
6 件公开
CONTROLLED TRANSGENE EXPRESSION IN REGULATORY T CELLS
EP 3973067 A1
申请人: SANGAMO THERAPEUTICS INC
优先权: 2019
CN
EP
US
WO
5 件公开
第 1 / 10 页
上一页
下一页
药物
反馈